(Q34621808)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20653908%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

review article

1 reference

title

Brain-derived neurotrophic factor as a biomarker for mood disorders: an historical overview and future directions (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20653908%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

0 references

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20653908%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

author name string

Kenji Hashimoto

series ordinal

1

1 reference

3 August 2017

1 August 2010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20653908%20AND%20SRC:MED&resulttype=core&format=json

Psychiatry and Clinical Neurosciences

8 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20653908%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

volume

64

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20653908%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20653908%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

page(s)

341-357

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20653908%20AND%20SRC:MED&resulttype=core&format=json

Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey

8 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2010.02113.X

Major Depressive Disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2010.02113.X

Development and natural history of mood disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2010.02113.X

Future of genetics of mood disorders research

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2010.02113.X

Neurobiology of depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2010.02113.X

Preclinical models: status of basic research in depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2010.02113.X

Managing bipolar disorders in children and adolescents

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2010.02113.X

Inflammation and its discontents: the role of cytokines in the pathophysiology of major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2010.02113.X

Biomarkers in psychiatry: drawbacks and potential for misuse

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2010.02113.X

Plasma protein biomarkers for depression and schizophrenia by multi analyte profiling of case-control collections

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2010.02113.X

Neurotrophins: roles in neuronal development and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2010.02113.X

The neurotrophin hypothesis for synaptic plasticity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2010.02113.X

The yin and yang of neurotrophin action

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2010.02113.X

Neurotrophin signalling in health and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2010.02113.X

Neurotrophin-regulated signalling pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2010.02113.X

A common thread for pain and memory synapses? Brain-derived neurotrophic factor and trkB receptors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2010.02113.X

BDNF: a key regulator for protein synthesis-dependent LTP and long-term memory?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2010.02113.X

Cellular processing of the neurotrophin precursors of NT3 and BDNF by the mammalian proprotein convertases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2010.02113.X

Biosynthesis and post-translational processing of the precursor to brain-derived neurotrophic factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2010.02113.X

New insights in the biology of BDNF synthesis and release: implications in CNS function

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2010.02113.X

Regulation of cell survival by secreted proneurotrophins

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2010.02113.X

Cleavage of proBDNF by tPA/plasmin is essential for long-term hippocampal plasticity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2010.02113.X

Activation of p75NTR by proBDNF facilitates hippocampal long-term depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2010.02113.X

ProBDNF induces neuronal apoptosis via activation of a receptor complex of p75NTR and sortilin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2010.02113.X

Pro-region of neurotrophins: role in synaptic modulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2010.02113.X

BDNF variant linked to anxiety-related behaviors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2010.02113.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2010.02113.X

Antidepressant-like effect of brain-derived neurotrophic factor (BDNF).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2010.02113.X

Physical activity-antidepressant treatment combination: impact on brain-derived neurotrophic factor and behavior in an animal model

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2010.02113.X

Brain-derived neurotrophic factor in the ventral midbrain-nucleus accumbens pathway: a role in depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2010.02113.X

Mice lacking brain-derived neurotrophic factor develop with sensory deficits

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2010.02113.X

Targeted disruption of the BDNF gene perturbs brain and sensory neuron development but not motor neuron development.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2010.02113.X

Effects of electroconvulsive seizures and antidepressant drugs on brain-derived neurotrophic factor protein in rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2010.02113.X

Hippocampal long-term potentiation is impaired in mice lacking brain-derived neurotrophic factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2010.02113.X

Brain-derived neurotrophic factor levels in the nervous system of wild-type and neurotrophin gene mutant mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2010.02113.X

Brain-derived neurotrophic factor-deficient mice develop aggressiveness and hyperphagia in conjunction with brain serotonergic abnormalities

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2010.02113.X

Dietary restriction changes behaviours in brain-derived neurotrophic factor heterozygous mice: role of serotonergic system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2010.02113.X

BDNF regulates eating behavior and locomotor activity in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2010.02113.X

Assessing antidepressant activity in rodents: recent developments and future needs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2010.02113.X

Brain-derived neurotrophic factor conditional knockouts show gender differences in depression-related behaviors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2010.02113.X

Selective loss of brain-derived neurotrophic factor in the dentate gyrus attenuates antidepressant efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2010.02113.X

Genetic variant BDNF (Val66Met) polymorphism alters anxiety-related behavior

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2010.02113.X

A molecular and cellular theory of depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2010.02113.X

Neurotrophins and depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2010.02113.X

Finding the Intracellular Signaling Pathways Affected by Mood Disorder Treatments

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2010.02113.X

New insights into BDNF function in depression and anxiety

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2010.02113.X

Behavioral and serotonergic consequences of decreasing or increasing hippocampus brain-derived neurotrophic factor protein levels in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2010.02113.X

Emerging role of glutamate in the pathophysiology of major depressive disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2010.02113.X

Exercise, antidepressant medications, and enhanced brain derived neurotrophic factor expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2010.02113.X

Repeated stress increases catalytic TrkB mRNA in rat hippocampus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2010.02113.X

Stress increases brain-derived neurotropic factor messenger ribonucleic acid in the hypothalamus and pituitary.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2010.02113.X

Developing novel treatments for mood disorders: accelerating discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2010.02113.X

Electroconvulsive therapy for depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2010.02113.X

Mapping the differences in the brain concentration of brain-derived neurotrophic factor (BDNF) and nerve growth factor (NGF) in an animal model of depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2010.02113.X

Hippocampal mossy fiber sprouting induced by chronic electroconvulsive seizures.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2010.02113.X

Site-specific antidepressant effects of repeated subconvulsive electrical stimulation: potential role of brain-derived neurotrophic factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2010.02113.X

Slow transcranial magnetic stimulation, long-term depotentiation, and brain hyperexcitability disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2010.02113.X

Transcranial magnetic stimulation in the treatment of depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2010.02113.X

Efficacy of repetitive transcranial magnetic stimulation (rTMS) in the treatment of affective disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2010.02113.X

Molecular basis of lithium action: integration of lithium-responsive signaling and gene expression networks

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2010.02113.X

Enhancing neuronal plasticity and cellular resilience to develop novel, improved therapeutics for Difficult-to-Treat depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2010.02113.X

Chronic lithium treatment increases the expression of brain-derived neurotrophic factor in the rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2010.02113.X

Lithium induces brain-derived neurotrophic factor and activates TrkB in rodent cortical neurons: an essential step for neuroprotection against glutamate excitotoxicity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2010.02113.X

Neuroprotective and neurotrophic actions of the mood stabilizer lithium: can it be used to treat neurodegenerative diseases?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2010.02113.X

Human and rat brain-derived neurotrophic factor and neurotrophin-3: gene structures, distributions, and chromosomal localizations

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2010.02113.X

The BDNF val66met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2010.02113.X

Toward molecular diagnostics of mood disorders in psychiatry

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2010.02113.X

Manic-depression genes and the new millennium: poised for discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2010.02113.X

Linkage analysis in psychiatric disorders: the emerging picture

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2010.02113.X

Association study of a brain‐derived neurotrophic‐factor genetic polymorphism and major depressive disorders, symptomatology, and antidepressant response

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2010.02113.X

Association study of a brain-derived neurotrophic-factor genetic polymorphism and mood disorders, age of onset and suicidal behavior

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2010.02113.X

The Val66Met polymorphism of the brain-derived neurotrophic factor gene is associated with psychotic feature and suicidal behavior in Japanese major depressive patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2010.02113.X

Association of polymorphism (Val66Met) of brain-derived neurotrophic factor with suicide attempts in depressed patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2010.02113.X

The Val66Met polymorphism of the brain-derived neurotrophic-factor gene is associated with geriatric depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2010.02113.X

Role of BDNF Val66Met functional polymorphism in Alzheimer's disease-related depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2010.02113.X

Evidence for a relationship between genetic variants at the brain-derived neurotrophic factor (BDNF) locus and major depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2010.02113.X

Novel sequence variations in the brain-derived neurotrophic factor gene and association with major depression and antidepressant treatment response

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2010.02113.X

Brain-derived neurotrophic factor ( BDNF) gene: no major impact on antidepressant treatment response

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2010.02113.X

Meta-analysis of BDNF Val66Met polymorphism association with treatment response in patients with major depressive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2010.02113.X

Association of genetic variants in the neurotrophic receptor-encoding gene NTRK2 and a lifetime history of suicide attempts in depressed patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2010.02113.X

Hippocampal atrophy in recurrent major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2010.02113.X

Hippocampal volume reduction in major depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2010.02113.X

Hippocampal volume and depression: a meta-analysis of MRI studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2010.02113.X

Brain volume abnormalities in major depressive disorder: a meta-analysis of magnetic resonance imaging studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2010.02113.X

Association of the brain-derived neurotrophic factor Val66Met polymorphism with reduced hippocampal volumes in major depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2010.02113.X

Neuroimaging genetics: new perspectives in research on major depression?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2010.02113.X

Ethnic difference of the BDNF 196G/A (val66met) polymorphism frequencies: the possibility to explain ethnic mental traits.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2010.02113.X

The brain-derived neurotrophic factor gene confers susceptibility to bipolar disorder: evidence from a family-based association study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2010.02113.X

Family-based association study of 76 candidate genes in bipolar disorder: BDNF is a potential risk locus. Brain-derived neutrophic factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2010.02113.X

Association between brain-derived neurotrophic factor gene and a severe form of bipolar disorder, but no interaction with the serotonin transporter gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2010.02113.X

Association study of the brain-derived neurotrophic factor (BDNF) gene with bipolar disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2010.02113.X

Postmortem studies in mood disorders indicate altered numbers of neurons and glial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2010.02113.X

Expression of hippocampal brain-derived neurotrophic factor and its receptors in Stanley consortium brains.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2010.02113.X

Suicide prevention strategies: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2010.02113.X

Suicide attempts in bipolar I and bipolar II disorder: a review and meta-analysis of the evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2010.02113.X

Altered gene expression of brain-derived neurotrophic factor and receptor tyrosine kinase B in postmortem brain of suicide subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2010.02113.X

Neurotrophin levels in postmortem brains of suicide victims and the effects of antemortem diagnosis and psychotropic drugs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2010.02113.X

Brain-derived neurotrophic factor and tyrosine kinase B receptor signalling in post-mortem brain of teenage suicide victims

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2010.02113.X

Alternative splicing, methylation state, and expression profile of tropomyosin-related kinase B in the frontal cortex of suicide completers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2010.02113.X

Increased BDNF promoter methylation in the Wernicke area of suicide subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2010.02113.X

Presence of brain-derived neurotrophic factor in brain and human and rat but not mouse serum detected by a sensitive and specific immunoassay.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2010.02113.X

Transport of brain-derived neurotrophic factor across the blood-brain barrier.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2010.02113.X

Postnatal developmental profile of brain-derived neurotrophic factor in rat brain and platelets.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2010.02113.X

Decreased serum brain-derived neurotrophic factor levels in major depressed patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2010.02113.X

Alterations of serum levels of brain-derived neurotrophic factor (BDNF) in depressed patients with or without antidepressants

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2010.02113.X

Plasma and serum brain-derived neurotrophic factor (BDNF) in depressed patients during 1 year of antidepressant treatments.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2010.02113.X

Brain-derived neurotrophic factor (BDNF) changes in the serum of depressed women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2010.02113.X

Effects of paroxetine or milnacipran on serum brain-derived neurotrophic factor in depressed patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2010.02113.X

Serum brain-derived neurotrophic factor level in dysthymia: a comparative study with major depressive disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2010.02113.X

Effect of treatment on serum brain-derived neurotrophic factor levels in depressed patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2010.02113.X

Serum brain-derived neurotrophic factor, depression, and antidepressant medications: meta-analyses and implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2010.02113.X

A systematic review and meta-analysis of clinical studies on major depression and BDNF levels: implications for the role of neuroplasticity in depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2010.02113.X

Plasma BDNF and tPA are associated with late-onset geriatric depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2010.02113.X

Electroconvulsive Therapy (ECT) increases serum Brain Derived Neurotrophic Factor (BDNF) in drug resistant depressed patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2010.02113.X

Efficacy of electroconvulsive therapy is associated with changing blood levels of homovanillic acid and brain-derived neurotrophic factor (BDNF) in refractory depressed patients: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2010.02113.X

The level of serum brain-derived neurotrophic factor is associated with the therapeutic efficacy of modified electroconvulsive therapy in Chinese patients with depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2010.02113.X

Serum brain-derived neurotrophic factor (BDNF) is not associated with response to electroconvulsive therapy (ECT): a pilot study in drug resistant depressed patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2010.02113.X

Neurotrophic factors in serum following ECT: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2010.02113.X

Acute prefrontal cortex transcranial magnetic stimulation in healthy volunteers: no effects on brain-derived neurotrophic factor (BDNF) concentrations in serum.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2010.02113.X

Serum brain-derived neurotrophic factor is decreased in bipolar disorder during depressive and manic episodes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2010.02113.X

Decreased levels of plasma BDNF in first-episode schizophrenia and bipolar disorder patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2010.02113.X

Decreased plasma brain derived neurotrophic factor levels in unmedicated bipolar patients during manic episode

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2010.02113.X

Decreased brain-derived neurotrophic factor in medicated and drug-free bipolar patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2010.02113.X

Effect of risperidone on plasma catecholamine metabolites and brain-derived neurotrophic factor in patients with bipolar disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2010.02113.X

Changes in brain-derived neurotrophic factor following treatment with mifepristone in bipolar disorder and schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2010.02113.X

Brain-derived neurotrophic factor and inflammatory markers in patients with early- vs. late-stage bipolar disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2010.02113.X

Cognitive function and serum levels of brain-derived neurotrophic factor in patients with bipolar disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2010.02113.X

State-dependent decrease in levels of brain-derived neurotrophic factor in bipolar disorder: a meta-analytic study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2010.02113.X

Management of psychiatric comorbidity in anorexia nervosa and bulimia nervosa

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2010.02113.X

The relationship between panic disorder and major depression. A new family study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2010.02113.X

Psychiatric comorbidities and schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2010.02113.X

Decreased levels of serum brain-derived neurotrophic factor in female patients with eating disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2010.02113.X

Circulating brain-derived neurotrophic factor is decreased in women with anorexia and bulimia nervosa but not in women with binge-eating disorder: relationships to co-morbid depression, psychopathology and hormonal variables

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2010.02113.X

Low serum BDNF and food intake regulation: a possible new explanation of the pathophysiology of eating disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2010.02113.X

Role of brain-derived neurotrophic factor in eating disorders: recent findings and its pathophysiological implications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2010.02113.X

Serum brain-derived neurotrophic factor (BDNF) levels in patients with panic disorder: as a biological predictor of response to group cognitive behavioral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2010.02113.X

Acute exercise ameliorates reduced brain-derived neurotrophic factor in patients with panic disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2010.02113.X

Serum brain-derived neurotrophic factor (BDNF) levels in schizophrenia are indistinguishable from controls.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2010.02113.X

Identification of pro- and mature brain-derived neurotrophic factor in human saliva

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2010.02113.X

BDNF Val66Met polymorphism and protein levels in amniotic fluid

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2010.02113.X

Role of the brain-derived neurotrophic factor at glutamatergic synapses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2010.02113.X

Glutamate and neurotrophic factors in neuronal plasticity and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2010.02113.X

The NMDA receptor as a therapeutic target in major depressive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2010.02113.X

Increased levels of glutamate in brains from patients with mood disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2010.02113.X

Targeting the glutamatergic system to develop novel, improved therapeutics for mood disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2010.02113.X

Glutamate-based antidepressants: 20 years on.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1819.2010.02113.X